Acumen Pharmaceuticals (NASDAQ:ABOS) Releases Earnings Results, Misses Expectations By $0.02 EPS

Acumen Pharmaceuticals (NASDAQ:ABOS – Get Free Report) issued its quarterly earnings results on Monday. The company reported ($0.25) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.23) by ($0.02), Zacks reports. During the same period last year, the firm posted ($0.28) earnings per share. Acumen Pharmaceuticals Stock Performance Shares of ABOS stock […]

Related Keywords

, News Ratings For Acumen Pharmaceuticals Daily , Earnings History For Acumen Pharmaceuticals , Acumen Pharmaceuticals Stock Performance , Acumen Pharmaceuticals Company Profile , Acumen Pharmaceuticals Inc , Acumen Pharmaceuticals , Get Free Report , Acumen Pharmaceuticals Daily ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.